Isakov V, Goncharov A. Breaking barriers in the first-line Helicobacter pylori treatment: Chinese multicenter trial validates vonoprazan-based triple therapy. World J Gastroenterol 2025; 31(40): 112312 [PMID: 41180991 DOI: 10.3748/wjg.v31.i40.112312]
Please LOGIN to submit a new comment.